SCHEMBL6282369

SCHEMBL6282369

COC(=O)[C@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)cc1)NCc1ccccc1Cl

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.65
PPARA Q07869 12/20 0.64
PPARD Q03181 5/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6277131 1.00 PPARG (0.65) PPARGPPARAPPARD
SCHEMBL6277184 0.93 PPARG (0.73) PPARGPPARAPPARD
SCHEMBL6282973 0.93 PPARG (0.73) PPARGPPARAPPARD
SCHEMBL6280374 0.90 PPARG (0.65) PPARGPPARAPPARD
SCHEMBL6284711 0.90 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL6281492 0.90 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL6286110 0.88 PPARG (0.62) PPARGPPARAPPARD
SCHEMBL6282823 0.88 PPARG (0.62) PPARGPPARAPPARD
SCHEMBL6280322 0.86 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL6282266 0.85 PPARG (0.61) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933309-B2 Halogenobenzyl aminopropionic acid derivatives TOAEIYO LTD. (JP) 2005-08-23 US disclosed
US-20040102439-A1 Halogenobenzyl aminopropionic acid derivatives TOAEIYO LTD. (JP) 2004-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102439-A1 Halogenobenzyl aminopropionic acid derivatives FABP4, SLC5A1, ALDH7A1 PPARG 34/4885PPARA 24/4885PPARD 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.